| Product Code: ETC8834570 | Publication Date: Sep 2024 | Updated Date: Jun 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Antimicrobial susceptibility testing (AST) is critical in the Philippines for determining the effectiveness of antibiotics against specific pathogens. The market benefits from increasing clinical laboratory capabilities and rising demand for personalized antimicrobial therapy, helping reduce inappropriate antibiotic use.
The antimicrobial susceptibility testing market in the Philippines is growing steadily due to the increasing prevalence of infectious diseases and rising antimicrobial resistance (AMR). Healthcare providers are increasingly adopting rapid diagnostic techniques to guide appropriate antibiotic therapy, reducing misuse and improving patient outcomes. Investments in advanced laboratory infrastructure and government support for AMR surveillance further stimulate market expansion.
This market encounters obstacles related to the availability of standardized testing kits and reagents, many of which depend on imports subject to delays and price fluctuations. Additionally, there is a shortage of skilled laboratory personnel trained to conduct and interpret susceptibility tests. The absence of widespread quality control and accreditation mechanisms further affects test reliability.
Susceptibility testing guides effective antibiotic use, reducing resistance. Investment in modern laboratory equipment, training, and decentralized testing services will enhance accessibility in the Philippines. Collaboration with hospitals, clinics, and government agencies can improve diagnostic coverage and quality.
Antimicrobial susceptibility testing (AST) is part of the mandated clinical practices under DOH guidelines and is critical for guiding antibiotic prescriptions. The FDA ensures all AST kits and instruments used in hospitals meet national and international performance standards. The National Reference Laboratory at RITM trains hospital microbiologists and ensures inter-laboratory accuracy through proficiency testing. Under the UHC framework, public health facilities are being equipped to perform AST as part of routine diagnostic workflows, and private laboratories must comply with the DOHâs licensing standards under the Health Facilities and Services Regulatory Bureau (HFSRB). Efforts to increase access to standardized AST aim to promote evidence-based antimicrobial use across the healthcare system.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Antimicrobial Susceptibility Testing Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Antimicrobial Susceptibility Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Antimicrobial Susceptibility Testing Market - Industry Life Cycle |
3.4 Philippines Antimicrobial Susceptibility Testing Market - Porter's Five Forces |
3.5 Philippines Antimicrobial Susceptibility Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Philippines Antimicrobial Susceptibility Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Philippines Antimicrobial Susceptibility Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Philippines Antimicrobial Susceptibility Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Antimicrobial Susceptibility Testing Market Trends |
6 Philippines Antimicrobial Susceptibility Testing Market, By Types |
6.1 Philippines Antimicrobial Susceptibility Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Philippines Antimicrobial Susceptibility Testing Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Philippines Antimicrobial Susceptibility Testing Market Revenues & Volume, By Manual Antimicrobial Susceptibility Testing, 2021- 2031F |
6.1.4 Philippines Antimicrobial Susceptibility Testing Market Revenues & Volume, By Automated Antimicrobial Susceptibility Testing Products, 2021- 2031F |
6.1.5 Philippines Antimicrobial Susceptibility Testing Market Revenues & Volume, By Consumables, 2021- 2031F |
6.2 Philippines Antimicrobial Susceptibility Testing Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Philippines Antimicrobial Susceptibility Testing Market Revenues & Volume, By Antibacterial Testing, 2021- 2031F |
6.2.3 Philippines Antimicrobial Susceptibility Testing Market Revenues & Volume, By Antifungal Testing, 2021- 2031F |
6.2.4 Philippines Antimicrobial Susceptibility Testing Market Revenues & Volume, By Antiparasitic Testing, 2021- 2031F |
6.2.5 Philippines Antimicrobial Susceptibility Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Philippines Antimicrobial Susceptibility Testing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Philippines Antimicrobial Susceptibility Testing Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.3.3 Philippines Antimicrobial Susceptibility Testing Market Revenues & Volume, By Drug Discovery and Development, 2021- 2031F |
6.3.4 Philippines Antimicrobial Susceptibility Testing Market Revenues & Volume, By Epidemiology, 2021- 2031F |
6.3.5 Philippines Antimicrobial Susceptibility Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Antimicrobial Susceptibility Testing Market Import-Export Trade Statistics |
7.1 Philippines Antimicrobial Susceptibility Testing Market Export to Major Countries |
7.2 Philippines Antimicrobial Susceptibility Testing Market Imports from Major Countries |
8 Philippines Antimicrobial Susceptibility Testing Market Key Performance Indicators |
9 Philippines Antimicrobial Susceptibility Testing Market - Opportunity Assessment |
9.1 Philippines Antimicrobial Susceptibility Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Philippines Antimicrobial Susceptibility Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Philippines Antimicrobial Susceptibility Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Philippines Antimicrobial Susceptibility Testing Market - Competitive Landscape |
10.1 Philippines Antimicrobial Susceptibility Testing Market Revenue Share, By Companies, 2024 |
10.2 Philippines Antimicrobial Susceptibility Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here